In patients having transjugular intrahepatic portosystemic shunt, rifaximin prevented overt hepatic encephalopathy. Koretz RL. Ann Intern Med 2021 Jul 6. doi: 10.7326/ACPJ202107200.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Koretz RL. In patients having transjugular intrahepatic portosystemic shunt, rifaximin prevented overt hepatic encephalopathy. Ann Intern Med 2021 Jul 6. doi: 10.7326/ACPJ202107200.
PMID: 34224266